Parithera
Switzerland, Switzerland
Parithera SA is developing an advanced liquid biopsy platform for real-time, single-cell analysis of circulating tumor cells (CTCs). Their system consists of two main components: ExTrace, an automated microfluidic device that isolates and barcodes CTCs from patient blood samples with high purity (~50%), and ExPlore, an AI-powered analytics suite that identifies biomarkers linked to treatment resistance and drug targets—especially for antibody-drug conjugates (ADCs) and other precision therapies.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.parithera.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Parithera?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now